AI assistant
LGI LIMITED — Director's Dealing 2023
Mar 7, 2023
65230_rns_2023-03-07_967e6c92-e714-4343-9195-8c7deb36830e.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity LGI Limited ABN 138 085 551
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Dr Jessica Catherine North |
|---|---|
| Date of last notice | 6 October 2022 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Direct or indirect interest Direct Nature of indirect interest (including registered holder) N/A Note: Provide details of the circumstances giving rise to the relevant interest. Date of change 1 March 2023
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to changeDr Jessica NorthDr Jessica Catherine North<Benjamin Kai Clynes A/c> | 1,299,200 Escrowed Fully Paid Ordinary**Shares (Escrowed Shares)**as follows:•433,068 shares escrowed until twobusiness days after the release of HalfYear 2023 results;•433,066 shares escrowed until twobusiness days after the release of FullYear 2023 results;•433,066 shares escrowed until twobusiness days after the release of HalfYear 2024 results.300,000 Escrowed Optionsexercisableat $0.70 per share, expiring on 31 January2025 as follows:•100,000 options escrowed until twobusiness days after the release of HalfYear 2023 results;•100,000 options escrowed until twobusiness days after the release of FullYear 2023 results;•100,000 options escrowed until twobusiness days after the release of HalfYear 2024 results.100,000 Escrowed Optionsexercisable at$0.925 per share, expiring on 31 January2025 as follows:•33,334optionsescroweduntiltwobusiness days after the release of HalfYear 2023 results;•33,333optionsescroweduntiltwobusiness days after the release of FullYear 2023 results;•33,333optionsescroweduntiltwobusiness days after the release of HalfYear 2024 results200 Fully Paid Ordinary Shares |
|---|---|
| Class | Shares and Options |
| Number acquired | N/A – escrow release |
| Number disposed | N/A – escrow release |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | Nil |
|---|---|
| No. of securities held after changeDr Jessica NorthDr Jessica Catherine North<Benjamin Kai Clynes A/c> | 1,299,200 Fully Paid Ordinary Shares**(Shares)**as follows:•433,068 unrestricted Shares;•433,066 Shares escrowed until twobusiness days after the release of FullYear 2023 results;•433,066 Shares escrowed until twobusiness days after the release of HalfYear 2024 results.300,000 Optionsexercisable at $0.70 pershare, expiring on 31 January 2025 asfollows:•100,000 unrestricted options;•100,000 options escrowed until twobusiness days after the release of FullYear 2023 results;•100,000 options escrowed until twobusiness days after the release of HalfYear 2024 results.100,000 Optionsexercisable at $0.925 pershare, expiring on 31 January 2025 asfollows:•33,334 unrestricted options;•33,333optionsescroweduntiltwobusiness days after the release of FullYear 2023 results;•33,333optionsescroweduntiltwobusiness days after the release of HalfYear 2024 results200 Fully Paid Ordinary Shares |
| Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back | The release of shares and options fromvoluntary escrow. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 3
Appendix 3Y Change of Director’s Interest Notice
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder(if issued securities) | N/A |
| Date of change | N/A |
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation | N/A |
| Interest after change | N/A |
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? | NO |
| If so, was prior written clearance provided to allow thetrade to proceed during this period? | N/A |
| If prior written clearance was provided, on what date wasthis provided? | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 4
01/01/2011